Selahattin Alperen Uysal

Machine Learning-Based Gene Signature Detection Highlights CXCL12 as a Key Marker for AML Prediction

Background: Acute myeloid leukemia (AML) is a severe hematologic malignancy marked by uncontrolled proliferation and impaired differentiation of myeloid cells, disrupting normal hematopoiesis and resulting in poor clinical outcomes. Conventional diagnostic approaches often lack the precision to accurately classify AML...